A binding site model and structure-activity relationships for the rat A3 adenosine receptor

Molecular Pharmacology

Volumn 45, Issue 6, 1994, Pages 1101-1111

  Van Galen, Philip J M ^a   Van Bergen, Andrew H ^a   Gallo Rodriguez, Carola ^a   Melman, Neli ^a   Olah, Mark E ^b   Ijzerman, A D P ^c   Stiles, Gary L ^b   Jacobson, Kenneth A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Ctr for Bio Pharmaceutical Sciences ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLXANTHINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 ANILINOADENOSINE; 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 CHLOROADENOSINE; 3 DEAZAADENOSINE; 3 METHYLXANTHINE; 6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; 6 N [2 (4 AMINOPHENYL)ETHYL]ADENOSINE; 7 METHYLXANTHINE; 8 BROMO CYCLIC AMP; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE DERIVATIVE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; AMILORIDE; CAFFEINE; CORDYCEPIN; CYTIDINE; DEOXYADENOSINE; GUANOSINE; INOSINE; MERCAPTOPURINE RIBOSIDE; RECEPTOR SUBTYPE; THEOBROMINE; THEOPHYLLINE; THIOGUANOSINE; THYMIDINE; UNINDEXED DRUG; URIDINE; XANTHINE DERIVATIVE; XANTHOSINE;

ANIMAL CELL; ARTICLE; CHO CELL; DRUG BINDING SITE; DRUG POTENCY; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; NONHUMAN; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ADENYLATE CYCLASE; ANIMALS; BINDING SITES; CHO CELLS; CRICETINAE; MODELS, MOLECULAR; RADIOLIGAND ASSAY; RATS; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0028337831     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. 2 receptors: structure-function relationships. Med. Res. Rev. 12:423-471 (1992).
2. Jacobson, K. A., P. J. M. van Galen, and M. Williams. Perspective. Adenosine receptors: pharmacology, structure-activity relationships and therapeutic potential. J. Med. Chem. 35:407-422 (1992).
3. 3 adenosine receptor. Proc. Natl. Acad. Sci. U. S. A. 89:7432-7436 (1992).
4. Meyerhof, W., R. Müller-Brechlin, and D. Richter. Molecular cloning of a novel putative G protein-coupled receptor expressed during rat spermiogenesis. FEBS Lett. 284:155-160 (1991).
5. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268:16887-16890 (1993).
6. 1 adenosine receptor. Identification of the binding subunit by photoaffinity cross-linking. J. Biol. Chem. 260:10806-10811 (1985).
7. van Galen, P. J. M., A. P. Ijzerman, and W. Soudijn. Xanthine-7 ribosides as adenosine receptor antagonists. Nucleos. Nucleot. 9:275-291 (1990).
8. 1H-imidazo[4,5-c]quinolin-4-amines: novel nonxanthine adenosine antagonists. J. Med. Chem. 34:1202-1206 (1991).
9. 6-sulfoalkyl derivatives of adenosine. Water-soluble and peripherally selective adenosine agonists. J. Med. Chem. 35:4143-4149 (1992).
10. 2 adenosine receptors. J. Med. Chem. 29:1683-1689 (1986).
11. 50) of an enzyme reaction. Biochem. Pharmacol. 22:3099-3108 (1973).
12. 1 receptor. Drug Design Dev. 9:49-68 (1992).
13. Bruns, R. F. Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can. J. Physiol Pharmacol. 58:673-691 (1980).
14. 1 receptor. J. Med. Chem. 35:629-635 (1992).
15. Henderson, R., J. M. Baldwin, T. A. Ceska, F. Zemlin, E. Beckman, and K. H. Downing. Model for the structure of bacteriorhodopsin based on high resolution electron cryo-microscopy. J. Mol. Biol. 213:899-929 (1990).
16. Hibert, M. F., S. Trumpp-Kallmeyer, J. Hoflack, and A. Bruinvels. This is not a G protein-coupled receptor. Trends Pharmacol. Sci. 14:7-12 (1993).
17. 1 adenosine receptors in rat brain membranes. Evidence for histidine in different domains of the ligand binding site. J. Biol. Chem. 263:17522-17526 (1988).
18. 1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. J. Biol. Chem. 267:10764-10770 (1992).
19. van Galen, P. J. M., A. P. Ijzerman, and W. Soudijn. Xanthine-7 ribosides as adenosine receptor antagonists. Further evidence for adenosine's anti mode of binding. Nucleos. Nucleot. 10:1191-1193 (1991).
20. Linden, J., A. L. Tucker, A. S. Robeva, S. G. Graber, and R. Munshi. Properties of recombinant adenosine receptors. Drug Dev. Res. 28:232-236 (1993).
21. 1 receptors. Int. J. Purine Pyrimidine Res. 3:65 (1992).
22. Daly, J. W., and K. A. Jacobson. Molecular probes for adenosine receptors, in Adenosine Receptors in the Nervous System (J. A. Ribeiro, ed.). Taylor & Francis, London, 41-52 (1989).
23. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29:331-346 (1986).
24. 6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity. J. Med. Chem. 30:1709-1711 (1987).
25. Trivedi, B. K. Structure-activity relationships for adenosine agonists, in Purines in Cellular Signalling. Targets for New Drugs (K. A. Jacobson, J. W. Daly, and V. Manganiello, eds.). Springer, New York, 136-145 (1990).
26. Cristalli, G., P. Franchetti, M. Grifantini, S. Vittori, K.-N. Klotz, and M. J. Lohse. Adenosine receptor agonists: synthesis and biological evaluation of 1-deaza analogues of adenosine derivatives. J. Med. Chem. 31:1179-1183 (1988).
27. 2 adenosine Receptors. J. Med. Chem. 34:3388-3390 (1991).
28. 2 receptor agonists in a series of N-alkylated 2-aminoadenosines. J. Med. Chem. 34:2570-2579 (1991).
29. 2-adenosine receptors coupled to adenylate cyclase. Biochem. Pharmacol. 43:1089-1093 (1992).
30. Cristalli, G., M. Grifantini, and S. Vittori. Adenosine and 2-chloroadenosine deaza analogues as adenosine receptor antagonists. Nucleos. Nucleot. 4:625-639 (1985).
31. 6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptors. Eur. J. Pharmacol. 156:157-160 (1988).
32. Sarges, R., H. R. Howard, R. G. Browne, L. A. Lebel, P. A. Seymour, and B. K. Koe. 4-Amino[1,2,4]triazolo[4,3-α]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. J. Med. Chem. 33:2240-2254 (1990).
33. Francis, J. E., W. D. Cash, S. Psychoyos, G. Ghai, P. Wenk, R. C. Friedmann, C. Atkins, V. Warren, P. Furness, J. L. Hyun, G. A. Stone, M. Desai, and M. Williams. Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists. J. Med. Chem. 31:1014-1020 (1988).
34. 1-adenosine receptor. J. Med. Chem. 34:2877-2882 (1991).
35. + exchanger but indicates a common structure on receptor proteins. J. Recept. Res. 11:891-907 (1991).
36. 2 adenosine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 330:212-221 (1985).
37. Shamim, M. T., D. Ukena, W. L. Padgett, and J. W. Daly. Effects of 8-phenyl and 8-cycloalkyl substituents on the activity of mono-, di-, and trisubstituted alkylxanthines with substitution at the 1, 3, and 7 positions. J. Med. Chem. 32:1231-1237 (1989).
38. Daly, J. W., P. Butts-Lamb, and W. Padgett. Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell. Mol. Neurobiol. 3:69-80 (1983).
39. Daly, J. W., W. L. Padgett, and M. T. Shamim. Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors. J. Med. Chem. 29:1305-1308 (1986).
40. Schneller, S. W., A. C. Ibay, W. J. Christ, and R. F. Bruns. Linear and proximal benzo-separated alkylated xanthines as adenosine-receptor antagonists. J. Med. Chem. 32:2247-2254 (1989).
41. Daly, J. W., I. Hide, and P. K. Bridson. Imidazodiazepinediones: a new class of adenosine receptor antagonists. J. Med. Chem. 33:2818-2821 (1990).
42. 1-adenosine receptors. FASEB J. 5:2668-2676 (1991).
43. Jacobson, K. A., K. L. Kirk, W. L. Padgett, and J. W. Daly. Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. J. Med. Chem. 28:1334-1340 (1985).
44. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br. J. Pharmacol. 109:3-5 (1993).
45. 2 receptor. Eur. J. Pharmacol., in press.
46. Jacobson, K. A., D. Shi, C. Gallo-Rodriguez, M. Manning, C. Müller, J. W. Daly, J. L. Neumeyer, L. Kiriasis, and L. Pfleiderer. Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors. J. Med. Chem. 36:2639-2644 (1993).
47. 2-selective adenosine antagonists. J. Med. Chem. 36:1333-1342 (1993).
48. 1 receptor and ligand molecular modeling. Drug Dev. Res. 28:237-243 (1993).